Related Experiment Video
Updated: Oct 29, 2025
05:55
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
1.0K
Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review
Paul M Elsbernd1, Jonathan L Carter1
1Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA.
Biologics : Targets & Therapy
|July 8, 2021
Summary
Monoclonal antibodies are effective treatments for multiple sclerosis (MS), offering convenient dosing and manageable side effects. This review details their mechanisms, approval evidence, and clinical considerations for MS management.
Area of Science:
- Neuroimmunology
- Pharmacology
Background:
- Monoclonal antibodies are crucial in managing multiple sclerosis (MS), a chronic neurological disease.
- Their efficacy, dosing convenience, and safety profiles make them vital therapeutic options.
Purpose of the Study:
- To review current monoclonal antibody therapies for multiple sclerosis.
- To summarize their mechanisms of action, approval evidence, and clinical considerations.
Main Methods:
- Literature review of approved monoclonal antibody therapies for MS.
- Analysis of mechanisms of action, clinical trial data, and safety profiles.
Main Results:
- Multiple monoclonal antibodies are approved for relapsing and progressive MS.
- Each therapy exhibits distinct efficacy, risks, and benefits based on its mechanism.
Conclusions:
- Understanding individual monoclonal antibody profiles is key for personalized MS treatment decisions.
- This review provides a comprehensive guide for clinicians utilizing these therapies.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
2.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.2K
01:19Mesenchymal Stem Cells
5.2K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
268
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
268